DOSSIERS / SANOFI 2020 D
← SearchExport PDF
Company dossier

SANOFI 2020 D

FRANCE · COMPANY · INCORPORATED 2020-12-30
KYBE ID: FR-892479353 · 892479353 · 1 sources
RISK SCORE37MEDIUM RISK
OverviewOwnershipPeopleRisk signals 3Sources

Key facts

dissolved
SANOFI 2020 D
fr_insee
892479353
fr_insee
dissolved
fr_insee
Simplified joint-stock company (SAS)
fr_insee
2020-12-30
fr_insee
82 AV RASPAIL, 94250 GENTILLY
fr_insee
70.10Z
fr_insee
€10,000
fr_insee

Ownership structure

1 entities

No ownership links on record for this entity.

Companies at this address

25 total
AVENTIS AGRICULTUREactiveAVENTIS PHARMA EURLactiveBIOCITECH SASdissolvedGROUPEMENT DE FABRICATION PHARMACEUTIQUEdissolvedKIADIS PHARMA FRANCEdissolvedLUGAN ET CIEdissolvedSANOFI 2015 CdissolvedSANOFI 2015 DdissolvedSANOFI 2018 AdissolvedSANOFI 2020 AdissolvedSANOFI 2020 CdissolvedSANOFI-AVENTIS FRANCEdissolvedSANOFI-AVENTIS GROUPEactiveSANOFI AVENTIS PARTICIPATIONSactiveSANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENTdissolvedSANOFI BIOTECHNOLOGYdissolvedSANOFI CHIMIEdissolvedSANOFI DEVELOPPEMENTdissolvedSANOFI DEVELOPPEMENT PHARMAdissolvedSANOFI MATURE IPdissolved

+5 more

People with significant control

2 people
NameRoleFromSource
PAULINE PEREIRADirecteur général délégué—France registry
ALEXANDRA JANE LAURENCE ROGERPrésident du conseil d'administration—France registry

Risk signals

3 matched
low

Clustered address

Address shared by 25 companies

high

Business fragmentation

A director is shared across 10 companies — business-splitting (дробление) pattern

high

Phoenix predecessor

Shares a director with a failed, near-identically-named company (SANOFI 2020 C · dissolved · name-sim 0.75) — phoenixing pattern (shed debts under a new company)

Risk journey — why 37?

3 signals
+16
Business fragmentation
+15
Phoenix predecessor
+6
Clustered address
Composite risk score37/100